Mainz Biomed B.V. logo

Mainz Biomed B.V.

NASDAQ:MYNZ

Overview | Financials
Company Name Mainz Biomed B.V.
Symbol MYNZ
Currency USD
Price 5
Market Cap 11,107,980
Dividend Yield 0%
52-week-range 0.18 - 7.95
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Guido Baechler
Website https://mainzbiomed.com

An error occurred while fetching data.

About Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a

Related Stocks

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

5.025 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.97 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

53.66 USD

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

0.744 USD

Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR

0.359 USD

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.55 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

7.38 USD

Financials

Numbers are in millions USD

Numbers are in millions USD